Original Article
 

Efficacy of Single-port Thoracoscopic Resection of Benign Lung Tumors and Its Impacts on Respiratory Function and Inflammatory Factors: A Randomized Controlled Study

Abstract

Peripheral benign lung tumors are often asymptomatic and incidentally detected on chest radiographs. Surgical intervention is recommended when feasible. Single-port thoracoscopic resection has emerged as a promising technique for treating various chest diseases, including lung tumors. This study aimed to assess the clinical efficacy of single-port thoracoscopic resection for benign lung tumors and its impact on respiratory function and inflammatory factors.
A total of 128 eligible patients diagnosed with benign lung tumors were randomly assigned to either the observation group (undergoing single-port thoracoscopic resection) or the control group (undergoing conventional thoracic surgery). Surgical outcomes, complications, pulmonary and respiratory function, and inflammatory factors were compared between the two groups.
The observation group showed significantly lower intraoperative bleeding, shorter hospitalization time, and lower complication rates compared to the control group. Patients in the observation group exhibited higher vital capacity (VC), forced vital capacity (FVC), and total lung capacity (TLC) levels at 1/2 week and 1 month after surgery. Additionally, forced expiratory volume in one second (FEV1) and maximum ventilation volume per minute (MVV) levels were higher in the observation group post-surgery, with a lower Borg score. Levels of C-reactive protein (CRP), precalcitonin (PCT), and tumor necrosis factor (TNF-α) were lower in the observation group post-surgery.
Single-port thoracoscopic resection demonstrates favorable clinical efficacy for treating benign lung tumors, reducing bleeding, and shortening hospital stays. Furthermore, it improves lung and respiratory function while reducing inflammatory factors. This technique is safe, effective, and holds promise for wider application in managing benign lung tumors.

1. Chen Q, Lu Q, Fei X, Li C, Li B. Elevated tumor markers in a benign lung disease. J Cardiothorac Surg. 2021;16(1):308-14.
2. Huang CC, Hung ST, Chang WC, Sheu CY. Benign features of infection-related tumor-like lesions of the lung: A retrospective imaging review study. J Med Imaging Radiat Oncol. 2017;61(4):481-8.
3. Wu CY, Chen YY, Chang CC, Yen YT, Lai WW, Huang WL, et al. Single-port thoracoscopic anatomic resection for chronic inflammatory lung disease. BMC Surg. 2021;21(1):244.
4. Yu X, Zheng B, Zhang S, Zeng T, Chen H, Zheng W, et al. Feasibility and validity of double-arm specimen extraction method after partial lung resection in single-port thoracoscopic surgery. J Thorac Dis. 2019;11(9):3769-75.
5. Liu CY, Lin CS, Shih CH, Liu CC. Single-port video-assisted thoracoscopic surgery for lung cancer. J Thorac Dis. 2014;6(1):14-21.
6. Han KN, Kim HK, Choi YH. Comparison of single port versus multiport thoracoscopic segmentectomy. J Thorac Dis. 2016;8(Suppl 3):S279-S286.
7. Lin Y, Zheng W, Zhu Y, Guo Z, Zheng B, Chen C. Comparison of treatment outcomes between single-port video-assisted thoracoscopic anatomic segmentectomy and lobectomy for non-small cell lung cancer of early-stage: a retrospective observational study. J Thorac Dis. 2016;8(6):1290-6.
8. Mizukami Y, Takahashi Y, Adachi H. Single-Port vs Conventional Three-Port Video-Assisted Thoracoscopic Pulmonary Wedge Resection: Comparison of Postoperative Pain and Surgical Costs. Ann Thorac Cardiovasc Surg. 2021;27(2):91-96.
9. Jun Wang, Xia Liu, Di Dong, Jiangdian Song, Min Xu, Yali Zang, et al. Prediction of malignant and benign of lung tumor using a quantitative radiomic method. Annu Int Conf IEEE Eng Med Biol Soc. 2016;2016:1272-1275.
10. Petersen RH, Hansen HJ, Dirksen A, Pedersen JH. Lung cancer screening and video-assisted thoracic surgery. J Thorac Oncol. 2012;7(6):1026-1031.
11. Bedetti B, Solli P, Lawrence D, Panagiotopoulos N, Hayward M, Scarci M. Single port video-assisted thoracoscopic thymectomy. J Vis Surg. 2016;2(3):149.
12. Hu CG, Zheng K, Liu GH, Li ZL, Zhao YL, Lian JH, et al. Effectiveness and postoperative pain level of single-port versus two-port thoracoscopic lobectomy for lung cancer: a retrospective cohort study. Gen Thorac Cardiovasc Surg. 2021;69(2):318-25.
13. Han KN, Kim HK, Choi YH. Midterm outcomes of single port thoracoscopic surgery for major pulmonary resection. PLoS One. 2017;12(11):e0186857.
14. Liu CY, Hsu PK, Chien HC, Hsieh CC, Ting CK, Tsou MY. Tubeless single-port thoracoscopic sublobar resection: indication and safety. J Thorac Dis. 2018;10(6):3729-3737.
15. Huang L, Zheng B, Chen C, Zheng W, Zhu Y, Guo C. Zhongguo Fei Ai Za Zhi. 2018;21(4):287-95.
16. Wu Z, Wang Q, Wu C, Zhan T, Dong L, Fang S, et al. Three-port single-intercostal versus multiple-intercostal thoracoscopic lobectomy for the treatment of lung cancer: a propensity-matched analysis. BMC Cancer. 2019;19(1):8.
17. Wang Y, Wang Z, Yao F. The safety and feasibility of three-dimension single-port video-assisted thoracoscopic surgery for the treatment of early-stage lung cancer. J Thorac Dis. 2020;12(12):7257-65.
18. Nakashima M, Suga N, Ikeda Y, Yoshikawa S, Matsuda S. Relevant MicroRNAs of MMPs and TIMPs with Certain Gut Microbiota Could Be Involved in the Invasiveness and Metastasis of Malignant Tumors. Innov Discov, 2024; 1(2): 10. DOI: 10.53964/id.2024010.
19. Ma S, Yan T, Wang K, Wang J, Song J, Wang T, et al. Zhongguo Fei Ai Za Zhi. 2018;21(2):99-103.
20. Nakashima M, Suga N, Ikeda Y, Yoshikawa S, Matsuda S. Relevant MicroRNAs of MMPs and TIMPs with Certain Gut Microbiota Could Be Involved in the Invasiveness and Metastasis of Malignant Tumors. Innov Discov, 2024; 1(2): 10. DOI: 10.53964/id.2024010.
21. Ng CS, Kim HK, Wong RH, Yim AP, Mok TS, Choi YH. Single-Port Video-Assisted Thoracoscopic Major Lung Resections: Experience with 150 Consecutive Cases. Thorac Cardiovasc Surg. 2016;64(4):348-53.
22. Zhao G, Jiang X, Wang F, Chu M, Zhang C, Zhao W, et al. Lobectomy with high-position single-intercostal two-port video-assisted thoracoscope for non-small cell lung cancer is a safe and effective surgical procedure. J Thorac Dis. 2020;12(12):7346-54.
Files
IssueVol 23 No 4 (2024) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijaai.v23i4.16214
Keywords
Benign lung tumor Clinical efficacy Inflammatory factors Respiratory function Single-port thoracoscopic resection

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Wang Q, Deng M, Wang B. Efficacy of Single-port Thoracoscopic Resection of Benign Lung Tumors and Its Impacts on Respiratory Function and Inflammatory Factors: A Randomized Controlled Study. Iran J Allergy Asthma Immunol. 2024;23(4):403-411.